Sort
39,280 grants matching “leukemia”
Training Program in Molecular Hematology
$634,805Nancy Berliner · Brigham And Women'S Hospital · T32 · FY2020 · HL
Combating melanoma resistance by targeting ABL1/2
$634,772Rina Plattner · University Of Kentucky · R01 · FY2022 · CA
Role of Genetic Susceptibility in Therapy-related Subsequent Malignancies
$634,757Smita Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2012 · CA
Tailoring CAR T cell therapy for Hodgkin Lymphoma
$634,693Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Tailoring CAR T cell therapy for Hodgkin Lymphoma
$634,693Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Genetic and molecular basis for SRSF2 mutations in myelodysplasia
$634,684Robert K Bradley · Fred Hutchinson Cancer Research Center · R01 · FY2017 · HL
Mutations of Chromatin and its Modifying Machineries in Malignancies
$634,659Ali Shilatifard · Northwestern University At Chicago · R35 · FY2015 · CA
ITSC for Leukemia: Novel Molecular strategies for NCTN "Individualized" Therapies
$634,586John C Byrd · University Of Cincinnati · UG1 · FY2022 · CA
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia
$634,568Neil E Kay · Mayo Clinic Rochester · R01 · FY2019 · CA
Implementation of an interventional, risk-adapted clinical trial for children with newly diagnosed juvenile myelomonocytic leukemia.
$634,503Elliot Stieglitz · University Of California, San Francisco · R37 · FY2024 · CA
Chromatin mobility in response to DNA damage
$634,406Pierre-Alexandre Vidi · Wake Forest University Health Sciences · U01 · FY2018 · CA
Developing Bioinformatic and Microfluidic Single Cell Methods for Studying Intratumoral Heterogeneity in Acute Myeloid Leukemia
$634,257Amy Paguirigan · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
New retroviral restriction factor
$634,167Tatyana V. Golovkina · University Of Chicago · R01 · FY2017 · AI
Targeting the menin-MLL1 complex for new therapeutics
$634,124Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Mesenchymal Regulation of Osteogenesis
$634,072Richard A Schneider · University Of California, San Francisco · R01 · FY2025 · DE
Mesenchymal Regulation of Osteogenesis
$634,072Richard A Schneider · University Of California, San Francisco · R01 · FY2023 · DE
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)
$633,969William E. Evans · St. Jude Children'S Research Hospital · R37 · FY2014 · CA
Integration of germline and tumor genomes in CLL
$633,873Susan L Slager · Mayo Clinic Rochester · R01 · FY2022 · CA
Processed Antigen Characterization by Mass Spectrometry
$633,862Donald F Hunt · University Of Virginia · R01 · FY2015 · AI
Project 1: Systematic discovery of cell-intrinsic mechanisms of cancer drug resistance
$633,787Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2019 · CA
Development of first-in-class ST2 inhibitors for treating graft-versus-host disease
$633,696Chao-Yie Yang · University Of Tennessee Health Sci Ctr · R01 · FY2022 · HL
Novel CAR T cell engineering strategies for effective eradication of solid and liquid tumors
$633,633Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2025 · CA
Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity
$633,596Aarti Asnani · Beth Israel Deaconess Medical Center · R01 · FY2024 · HL
Translation Fidelity in Hematopoietic Stem Cell Aging and Longevity
$633,555Robert A.j. Signer · University Of California, San Diego · R01 · FY2025 · AG
Targeting Menin in Acute Leukemia with Upregulated HOX Genes
$633,462Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2025 · CA